Wearable Artificial Organs Market To Reach $28.74 Billion By 2030

Wearable Artificial Organs Market Growth & Trends

The global wearable artificial organs market size is expected to reach USD 28.74 billion by 2030, registering a CAGR of 17.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing cases of transplant failure coupled with the increasing shortage of organ donors are creating massive growth opportunities for wearable artificial organs. Technological advancement in the field of 3D printing and artificial intelligence is creating new avenues for the market.

These devices are improving the patient’s quality of life by allowing them to continue their routine activities while undergoing therapy or dialysis. The market is expected to witness several product launches and FDA approvals. For instance, in December 2019, the FDA approved Tandem Diabetes Care’s Control-IQ artificial pancreas system. The device is an automatic insulin dosing system designed to deliver correction boluses. In August 2019, the FDA approved a MED-EL cochlear implant system for single-sided asymmetric hearing loss. This system is approved for use in children 5 years and older.

Increasing incidence of road accidents resulting in severe injuries also creates a demand for wearable artificial organs. According to the World Health Organization, approximately 1.4 million people die in a road accident every year, and around 20 to 50 million people suffer from non-fatal injuries.

 Request a free sample copy or view report summary: Wearable Artificial Organs Market Report

Wearable Artificial Organs Market Report Highlights

• The cochlear implant segment dominated the market with a revenue share of 29.5% in 2024, which can be attributed to its established efficacy in treating hearing loss. Cochlear implants have become a standard solution for individuals with severe to profound hearing impairment, leading to increased adoption rates.

• The electronic segment dominated the market with the largest revenue share in 2024, which can be attributed to advancements in electronic components that enhance device performance and patient comfort.

• North America wearable artificial organs market dominated the global market with a revenue share of 44.2% in 2024, which can be attributed to advanced healthcare infrastructure that supports the rapid development and adoption of innovative medical technologies.

• The Asia Pacific wearable artificial organs market is expected to register the highest CAGR of 19.2% over the forecast period, which can be attributed to the large patient pool and the high incidence of organ failure in the region.

Wearable Artificial Organs Market Segmentation

Grand View Research has segmented global wearable artificial organs market report based on artificial organs, technology, and region:

Wearable Artificial Organs Artificial Organ Outlook (Revenue, USD Million, 2018 - 2030)

• Kidney

• Pancreas

• Cochlear Implant

• Exoskeleton

• Bionic Limbs

• Brain Bionics

• Vision Bionics

Wearable Artificial Organs Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Mechanical

• Electronic

Wearable Artificial Organs Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Wearable Artificial Organs Market

• Medtronic

• Vivance

• Vivani Medical, Inc.

• Cochlear Ltd.

• Ekso Bionics

• MED-EL Medical Electronics

• Abbott

• Boston Scientific Corporation

• HDT Global

• ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD